| The Bid Idea: Prizes to Stimulate R& (and) D for New Medicines J Love, T Hubbard Chi.-Kent L. Rev. 82, 1519, 2007 | 210 | 2007 |
| A new trade framework for global healthcare R&D T Hubbard, J Love PLoS biology 2 (2), e52, 2004 | 158 | 2004 |
| Prizes for innovation of new medicines and vaccines J Love, T Hubbard Annals Health L. 18, 155, 2009 | 82 | 2009 |
| SOCIEDADE DA INFORMAÇÃO E J de Oliveira Ascensão, M Ress, ALD Pereira, FP Ramirez, J Love, ... Direito da sociedade da informação 1, 163-184, 1999 | 55 | 1999 |
| Recent examples of the use of compulsory licenses on patents JP Love Knowledge Ecology International 8, 2007 | 54 | 2007 |
| Pricing government information J Love Journal of Government Information 22 (5), 363-387, 1995 | 53 | 1995 |
| Measures to Enhance Access to Medical Technologies, and New Methods of Stimulating Medical R & D J Love UC Davis L. Rev. 40, 679, 2006 | 50 | 2006 |
| Evidence regarding research and development investments in innovative and non-innovative medicines J Love Washington DC: Consumer Project on Technology 22, 2003 | 48 | 2003 |
| Remuneration guidelines for non-voluntary use of a patent on medical technologies J Love UNDP, 2005 | 47 | 2005 |
| Paying for public goods J Love, T Hubbard Code: Collaborative ownership and the digital economy 207, 2005 | 30 | 2005 |
| A pandemic treaty for equitable global access to medical countermeasures: seven recommendations for sharing intellectual property, know-how and technology K Perehudoff, E Hoen, K Mara, T Balasubramaniam, F Abbott, B Baker, ... BMJ Global Health 7 (7), e009709, 2022 | 26 | 2022 |
| Compulsory Licensing: Models for State Practices in Developing Countries, Access to Medicine and Compliance with the WTO TRIPS Accord J Love Third World Network, 2004 | 24 | 2004 |
| Labeling changes and costs for clinical trials performed under the US Food and Drug Administration pediatric exclusivity extension, 2007 to 2012 MS Sinha, M Najafzadeh, EK Rajasingh, J Love, AS Kesselheim JAMA Internal Medicine 178 (11), 1458-1466, 2018 | 22 | 2018 |
| The production of generic drugs in India J Love BMJ 342, 2011 | 22 | 2011 |
| Policies that ensure access to medicine, and promote innovation, with special attention to issues concerning the impact of parallel trade on the competitive sector, and a trade … J Love WTO/WHO Meeting on Differential Pricing & Financing of Essential Drugs http …, 2001 | 19 | 2001 |
| Call for more reliable costs data on clinical trials J Love January, 1997 | 19 | 1997 |
| From TRIPS to RIPS: A better trade framework to support innovation in medical technologies J Love Available at http:⁄⁄ www. cptech. org/ip/health/rndtf/trips2rips. pdf via …, 2003 | 16 | 2003 |
| How much does it cost to develop a new drug J Love MSF Working Group Meeting on R&D, Geneva, 2000 | 16 | 2000 |
| Drug development incentives to improve access to essential medicines. JP Love Bulletin of the World Health Organization 84 (5), 408-409, 2006 | 15 | 2006 |
| The marketplace and electronic government information∗ JP Love Government Publications Review 19 (4), 397-412, 1992 | 15 | 1992 |
